Semma Therapeutics
is a biotechnology company that develops and commercializes stem cell-based therapies for the treatment of diabetes... Read moreSemma Therapeutics
is a biotechnology company that develops and commercializes stem cell-based therapies for the treatment of diabetes... Read more
News
Sep 18, 2019
MarketScreener
Semma Therapeutics: Living Cell Technologies : LCT to benefit from Semma Therapeutics Acquisition by Vertix
Sep 06, 2019
Business Insider India
Semma Therapeutics: Vertex shells out $950 million to acquire a company working on a diabetes cure
Sep 06, 2019
PharmiWeb
Semma Therapeutics: Vertex to Acquire Semma Therapeutics With a Goal of Developing Curative Cell-Based Treatments for Type 1 Diabetes
Sep 04, 2019
Pharamceutical Technology
Semma Therapeutics: Vertex-Semma $950m acquisition: bringing diabetes into the pipeline
Sep 04, 2019
BioPharma-Reporter
Semma Therapeutics: Vertex adds to deal spree with $950m for biotech seeking diabetes cure
Jul 02, 2019
BioCentury
Semma Therapeutics: July 2 Preclinical Quick Takes: Semma plans 2020 clinical trials of stem cell-derived islet products and more
Jul 01, 2019
BioPortfolio
Semma Therapeutics: Semma Therapeutics Announces PreClinical ProofofConcept in Two Lead Programs in Type 1 Diabetes
May 20, 2019
Manufacturing Chemist
Semma Therapeutics: Harvard and Semma Therapeutics improve insulin yield from stem cells
May 10, 2019
FierceBiotech
Semma Therapeutics: Harvard-born diabetes startup Semma reports advances in turning stem cells into insulin producers
May 08, 2019
BioPortfolio
Semma Therapeutics: Semma Therapeutics Announces Publication in Nature Demonstrating Advancements in Regenerative Cell Therapy for Type 1 Diabetes
Semma Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10